Cargando…
Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ(9)-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contain...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637868/ https://www.ncbi.nlm.nih.gov/pubmed/36353497 http://dx.doi.org/10.3389/fphar.2022.1038754 |
_version_ | 1784825278422319104 |
---|---|
author | Pigliasco, Federica Malaca, Sara Lo Faro, Alfredo Fabrizio Tini, Anastasio Cangemi, Giuliana Cafaro, Alessia Barco, Sebastiano Riva, Antonella Pisati, Angelica Amadori, Elisabetta Striano, Pasquale Tagliabracci, Adriano Huestis, Marilyn Ann Busardò, Francesco Paolo |
author_facet | Pigliasco, Federica Malaca, Sara Lo Faro, Alfredo Fabrizio Tini, Anastasio Cangemi, Giuliana Cafaro, Alessia Barco, Sebastiano Riva, Antonella Pisati, Angelica Amadori, Elisabetta Striano, Pasquale Tagliabracci, Adriano Huestis, Marilyn Ann Busardò, Francesco Paolo |
author_sort | Pigliasco, Federica |
collection | PubMed |
description | Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ(9)-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contains THC and CBD in different ratios, along with minor phytocannabinoids, terpenes, flavonoids and other chemicals. A volumetric absorptive microsampling (VAMS) method combined with ultra-high-performance liquid chromatography coupled with mass spectrometry in tandem for quantification of CBD, THC and their respective metabolites: cannabidiol-7-oic acid (7-COOH-CBD); 7-hydroxy-cannabidiol (7-OH-CBD); 6-alpha-hydroxy-cannabidiol (6-α-OH-CBD); and 6-beta-hydroxycannabidiol (6-β-OH-CBD); 11- Hydroxy-Δ(9)-tetrahydrocannabinol (11-OH-THC) and 11-Nor-9-carboxy-Δ(9)-tetrahydrocannabinol (THCCOOH). After overnight enzymatic glucuronide hydrolysis at 37°C, samples underwent acidic along with basic liquid-liquid extraction with hexane: ethyl acetate (9:1, v/v). Chromatographic separation was carried out on a C18 column, with the mass spectrometer operated in multiple reaction monitoring mode and negative electrospray ionization. Seven patients with intractable epilepsy were dosed with various CBD-containing formulations and blood collected just before their daily morning administration. The method was validated following international guidelines in toxicology. Linear ranges were (ng/ml) 0.5–25 THC, 11-OH-THC, THCCOOH, 6-α-OH-CBD and 6-β-OH-CBD; 10–500 CBD and 7-OH-CBD; and 20–5000 7-COOH-CBD. 7-COOH-CBD was present in the highest concentrations, followed by 7-OH-CBD and CBD. This analytical method is useful for investigating CBD, THC and their major metabolites in epilepsy patients treated with CBD preparations employing a minimally invasive microsampling technique requiring only 30 µL blood. |
format | Online Article Text |
id | pubmed-9637868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96378682022-11-08 Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients Pigliasco, Federica Malaca, Sara Lo Faro, Alfredo Fabrizio Tini, Anastasio Cangemi, Giuliana Cafaro, Alessia Barco, Sebastiano Riva, Antonella Pisati, Angelica Amadori, Elisabetta Striano, Pasquale Tagliabracci, Adriano Huestis, Marilyn Ann Busardò, Francesco Paolo Front Pharmacol Pharmacology Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ(9)-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contains THC and CBD in different ratios, along with minor phytocannabinoids, terpenes, flavonoids and other chemicals. A volumetric absorptive microsampling (VAMS) method combined with ultra-high-performance liquid chromatography coupled with mass spectrometry in tandem for quantification of CBD, THC and their respective metabolites: cannabidiol-7-oic acid (7-COOH-CBD); 7-hydroxy-cannabidiol (7-OH-CBD); 6-alpha-hydroxy-cannabidiol (6-α-OH-CBD); and 6-beta-hydroxycannabidiol (6-β-OH-CBD); 11- Hydroxy-Δ(9)-tetrahydrocannabinol (11-OH-THC) and 11-Nor-9-carboxy-Δ(9)-tetrahydrocannabinol (THCCOOH). After overnight enzymatic glucuronide hydrolysis at 37°C, samples underwent acidic along with basic liquid-liquid extraction with hexane: ethyl acetate (9:1, v/v). Chromatographic separation was carried out on a C18 column, with the mass spectrometer operated in multiple reaction monitoring mode and negative electrospray ionization. Seven patients with intractable epilepsy were dosed with various CBD-containing formulations and blood collected just before their daily morning administration. The method was validated following international guidelines in toxicology. Linear ranges were (ng/ml) 0.5–25 THC, 11-OH-THC, THCCOOH, 6-α-OH-CBD and 6-β-OH-CBD; 10–500 CBD and 7-OH-CBD; and 20–5000 7-COOH-CBD. 7-COOH-CBD was present in the highest concentrations, followed by 7-OH-CBD and CBD. This analytical method is useful for investigating CBD, THC and their major metabolites in epilepsy patients treated with CBD preparations employing a minimally invasive microsampling technique requiring only 30 µL blood. Frontiers Media S.A. 2022-10-24 /pmc/articles/PMC9637868/ /pubmed/36353497 http://dx.doi.org/10.3389/fphar.2022.1038754 Text en Copyright © 2022 Pigliasco, Malaca, Lo Faro, Tini, Cangemi, Cafaro, Barco, Riva, Pisati, Amadori, Striano, Tagliabracci, Huestis and Busardò. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Pigliasco, Federica Malaca, Sara Lo Faro, Alfredo Fabrizio Tini, Anastasio Cangemi, Giuliana Cafaro, Alessia Barco, Sebastiano Riva, Antonella Pisati, Angelica Amadori, Elisabetta Striano, Pasquale Tagliabracci, Adriano Huestis, Marilyn Ann Busardò, Francesco Paolo Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients |
title | Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients |
title_full | Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients |
title_fullStr | Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients |
title_full_unstemmed | Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients |
title_short | Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients |
title_sort | cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and lc-ms/ms following controlled administration in epilepsy patients |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637868/ https://www.ncbi.nlm.nih.gov/pubmed/36353497 http://dx.doi.org/10.3389/fphar.2022.1038754 |
work_keys_str_mv | AT pigliascofederica cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT malacasara cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT lofaroalfredofabrizio cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT tinianastasio cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT cangemigiuliana cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT cafaroalessia cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT barcosebastiano cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT rivaantonella cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT pisatiangelica cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT amadorielisabetta cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT strianopasquale cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT tagliabracciadriano cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT huestismarilynann cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients AT busardofrancescopaolo cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients |